The DH IRB has two IRBs that meet once per month.
IRB Session 1 (IRB-1) meets on the first Thursday of each month, and the IRB Session 2 (IRB-2) meets on the 3rd Thursday of each month.
The deadline to submit an item for review at an IRB meeting is two weeks less one day before the scheduled meeting. This is because each item to be reviewed by the IRB must be prepared and added to the agenda, which is sent to the DH IRB members one week before the meeting.
The IRB needs to review only studies that are considered to be greater than minimal risk, are of unknown risk, involve a drug, biologic, or device, and report certain new information.